Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
282 studies found for:    pharmacology + NICHD
Show Display Options
Rank Status Study
21 Recruiting Peripheral Nerve Stimulation for Shoulder Pain: Dose Response
Conditions: Stroke;   Shoulder Pain
Intervention: Device: Peripheral Nerve Stimulation
22 Terminated Obesity and Oral Contraceptive Failure
Conditions: Contraception;   Fetal Growth Retardation;   Infant, Small for Gestational Age;   Obesity
Intervention:
23 Completed
Has Results
Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
Conditions: Diabetes Mellitus;   Hypertension;   Metabolic Disease;   Obesity;   Sleep Apnea Syndrome
Interventions: Drug: Orlistat;   Drug: Placebo
24 Completed Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Saquinavir
25 Completed Fluconazole Pharmacokinetics in Infants
Condition: Fungal Infection
Intervention:
26 Completed Melatonin for Sleep in Children With Autism
Conditions: Autistic Disorder;   Insomnia
Interventions: Drug: supplemental liquid melatonin;   Drug: flavored liquid or liquid supplemental melatonin
27 Active, not recruiting Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
Condition: Niemann-Pick Disease, Type C1
Intervention: Drug: VTS-270
28 Unknown  Methadone Pharmacokinetics and Cardiac Effects in Newborns
Condition: Pain
Intervention: Drug: Methadone
29 Completed Trial of Aggressive Versus Conservative Phototherapy in Infants <1,000 Grams Birth Weight
Conditions: Hyperbilirubinemia, Neonatal;   Jaundice, Neonatal;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Aggressive Phototherapy 501-750g;   Procedure: Aggressive Phototherapy 751-1000g;   Procedure: Conservative Phototherapy 501-750g;   Procedure: Conservative Phototherapy 751-1000g
30 Completed
Has Results
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
Conditions: Pregnancy;   Unexplained Infertility
Interventions: Drug: Letrozole (aromatase inhibitor);   Drug: Clomiphene Citrate;   Drug: Follicle Stimulating Hormone (gonadotropin)
31 Completed Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns
Condition: Hyperbilirubinemia
Interventions: Drug: tin mesoporphyrin;   Procedure: Phototherapy
32 Completed Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Hyperbilirubinemia;   Hemolytic Disease of Newborn
Intervention: Drug: tin mesoporphyrin
33 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)
34 Completed
Has Results
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Conditions: Bacterial Infections;   Obesity
Intervention: Drug: Clindamycin
35 Completed Sodium Nitroprusside for Blood Pressure Reduction in the ICU (SNP2)
Condition: Hypertension
Interventions: Drug: nitroprusside;   Drug: placebo infusion
36 Completed Dose-Response Study of Sodium Nitroprusside in Children Requiring Controlled Hypotension in the Operating Room
Condition: Hypotension
Intervention: Drug: nitroprusside
37 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
38 Completed Diabetes Prevention Program
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   Glucose Intolerance
Intervention: Behavioral: Intensive lifestyle
39 Completed Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature
Conditions: Dwarfism;   Growth Disorder
Intervention: Drug: Deslorelin
40 Recruiting Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Condition: Neimann-Pick Disease
Intervention: Drug: Vorinostat

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.